NB

Neta Batscha

SVP of Corporate Strategy and Operations at Paragon Therapeutics, Inc.

Dallas-Fort Worth Metroplex

Overview

Work Experience

PT

Paragon Therapeutics, Inc.

  • SVP of Corporate Strategy and Operations

    2021 - Current

TB

The Beneficient Company Group, L.P.

  • VP, Biotech Investment Underwriting

    2020 - 2021

RC

RA Capital Management, L.P.

  • Venture Associate

    2019 - 2020

    Established firm’s presence in Texas, built relationships with academic institutions, investigators, and entrepreneurs in the region. Led due diligence for early-stage life science investment opportunities.

  • Equity Analyst

    2016 - 2019

    Led due diligence and investment in private and public biotechnology companies.

  • TechAtlas Associate

    2013 - 2015

    Built firm’s expertise in hematologic malignancies as founding member of the oncology team.

LT

Lyra Therapeutics

  • Board Observer

    2018 - 2020

SP

Satsuma Pharmaceuticals, Inc.

  • Board Observer

    2017 - 2020

Sojournix, Inc.

  • Board Observer

    2017 - 2020

TA

Tel Aviv Sourasky Medical Center's Dana-Dwek Children's Hospital

  • Clinical Research Assistant, Neonatal Unit, MIT-Israel Program

    2012 - 2012

MI

Massachusetts Institute of Technology (MIT)

  • Undergraduate Researcher, Krieger Lab

    2011 - 2011

    Researched role of C-transmembrane domain of SR-BI in receptor dimerization and selective lipid uptake from HDL.

CR

Congressional Research Service

  • Intern, CRS Domestic Social Policy Division, MIT Washington Program

    2011 - 2011

    Researched and drafted report on direct-to-consumer (DTC) genetic testing, regulatory environment, and potential policy solutions.

Cf

Center for Genomic Regulation (CRG)

  • Undergraduate Researcher, Graf Lab, MIT- MISTI Spain Program

    2010 - 2010

    Researched DNA modifications during trans-differentiation of B-cells to macrophages and role of cell differentiation in cancer.

Education

Relevant Websites